Letter to the editor regarding the paper by A. Lozano-Blazquez et al. Differences in cancer drug assessment between Spain and the United Kingdom
Por:
Prat, A, Gilabert, A, Puig-Peiro, R, Feliu, A, Riba, M, Mangues, MA, Tabernero, J
Publicada:
1 nov 2016
Resumen:
Filiaciones:
Prat, A:
Serv Catala Salut CatSalut, Pharm & Med Dept, Travessera Corts 131-159, Barcelona 08028, Spain
Gilabert, A:
Serv Catala Salut CatSalut, Pharm & Med Dept, Travessera Corts 131-159, Barcelona 08028, Spain
Puig-Peiro, R:
Serv Catala Salut CatSalut, Pharm & Med Dept, Travessera Corts 131-159, Barcelona 08028, Spain
Feliu, A:
Hosp Santa Creu & Sant Pau, Dept Pharm, Barcelona, Spain
Riba, M:
Hosp Santa Creu & Sant Pau, Dept Pharm, Barcelona, Spain
Mangues, MA:
Hosp Santa Creu & Sant Pau, Dept Pharm, Barcelona, Spain
Tabernero, J:
Vall dHebron Univ Hosp, Barcelona, Spain
Vall dHebron Inst Oncol, Barcelona, Spain
|